eResearchTechnology Issued a United States Patent For Methods and Systems for Processing Electrocardiograms

eResearchTechnology Issued a United States Patent For Methods and
Systems for Processing Electrocardiograms
Patent Includes More than 50 Claims Associated With eRT's Digital ECG
Processing Environment and EXPeRT(R) System and Methods 


PHILADELPHIA, June 2  /PRNewswire-FirstCall/ -- eResearchTechnology, Inc.
(eRT), (NASDAQ:ERES), a leading provider of centralized electrocardiographic
collection and interpretation services, announced today that it has been issued
United States Patent No. 6,708,057 (the '057 Patent) for various methods and
systems for processing electrocardio grams.  The methods and systems have
particular utility in the collection and interpretation of electrocardiograms
developed during clinical trials.

The '057 Patent includes more than 50 claims directed to various features of
eRT's EXPeRT(R) workflow enabled data handling technology, the first solution
in production that was designed explicitly to meet emerging international
regulatory guidance and technical standards. eRT's EXPeRT(R) system provides
integrated technology and processes across the entire lifecycle of a digital
ECG transaction, from collection, to analysis, management and distribution of
results.

Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.ert.com/) is a
provider of technology and services to the pharmaceutical, biotechnology and
medical device industries on a global basis.  The company is a market leader in
providing centralized core-diagnostic electrocardiographic technology and
services to evaluate cardiac safety in clinical development. The company is
also a leader in providing technology and services to streamline the clinical
trials process by enabling its customers to automate the collection, analysis,
and distribution of clinical data in all phases of clinical development.

Statements included in this release may constitute forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995.
Such statements involve a number of risks and uncertainties such as competitive
factors and technological development.  Further information on potential
factors that could affect the company's financial results can be found in the
company's Reports on Forms 10-K and 10-Q filed with the Securities and Exchange
Commission. 

DATASOURCE: eResearchTechnology, Inc.



CONTACT:  Joan Sterlacci of eResearchTechnology, [phone], or Matt

Hayden of Hayden Communications, [phone], for eResearchTechnology



Web site:  http://www.ert.com/

Copyright